Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Dividends Paid - Common (2019)

Historic Dividends Paid - Common for BridgeBio Pharma (BBIO) over the last 1 years, with Q3 2019 value amounting to $54.0 million.

  • BridgeBio Pharma's Dividends Paid - Common changed N/A to $54.0 million in Q3 2019 from the same period last year, while for Dec 2019 it was $55.0 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2020, which is 9091.09% down from last year.
  • Per BridgeBio Pharma's latest filing, its Dividends Paid - Common stood at $54.0 million for Q3 2019.
  • In the past 5 years, BridgeBio Pharma's Dividends Paid - Common ranged from a high of $54.0 million in Q3 2019 and a low of $997000.0 during Q1 2019